Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity-Reference-Cited by-同舟云学术

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity

Published:2021-05-27 Issue:11 Volume:64 Page:7809-7838
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Guzelj Samo¹,Nabergoj Sanja¹,Gobec Martina¹,Pajk Stane¹,Klančič Veronika¹,Slütter Bram²,Frkanec Ruža³,Štimac Adela³,Šket Primož⁴,Plavec Janez⁴,Mlinarič-Raščan Irena¹,Jakopin Žiga¹^ORCID

Affiliation:

1. Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia

2. Div. BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands

3. Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, 10000 Zagreb, Croatia

4. Slovenian NMR Centre, National Institute of Chemistry, SI-1000 Ljubljana, Slovenia

Funder

Javna Agencija za Raziskovalno Dejavnost RS

European Cooperation in Science and Technology

Hrvatska Zaklada za Znanost

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00644

Reference132 articles.

1. Approaching the Asymptote? Evolution and Revolution in Immunology

2. Innate Immune Recognition

3. Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm

4. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants

5. Targeting pattern-recognition receptors to discover new small molecule immune modulators

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines;Frontiers in Drug Delivery;2024-07-16

2. Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response;International Journal of Molecular Sciences;2024-05-13

3. Structure-activity relationship in NOD2 agonistic muramyl dipeptides;European Journal of Medicinal Chemistry;2024-05

4. Di-mannosylation enhances the adjuvant properties of adamantane-containing desmuramyl peptides in vivo;Organic & Biomolecular Chemistry;2024

5. N-Arylpyrazole NOD2 Agonists Promote Immune Checkpoint Inhibitor Therapy;ACS Chemical Biology;2023-05-12